<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="letter" dtd-version="2.3" xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SCIENCE</journal-id>
<journal-title>Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Science</abbrev-journal-title>
<issn pub-type="ppub">0036-8075</issn>
<issn pub-type="epub">1095-9203</issn>
<publisher>
<publisher-name>American Association for the Advancement of Science</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-categories>
<subj-group subj-group-type="article-type"><subject>Letter</subject></subj-group>
<subj-group subj-group-type="heading"><subject>Letters</subject></subj-group>
<subj-group subj-group-type="legacy-article-type"><subject>letters</subject></subj-group>
<subj-group subj-group-type="display-ad"><subject>Neuroscience</subject><subject>Physiology</subject><subject>Microbiology</subject></subj-group>
</article-categories>
<title-group>
<article-title>Strategy Behind Science Policy Decisions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Juliano</surname><given-names>Rudy</given-names></name></contrib>
<aff id="aff1">UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.</aff>
</contrib-group>
<author-notes>
<corresp>E-mail: <email>arjay@medunc.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>26</day>
<month>04</month>
<year>2013</year>
</pub-date>
<volume>340</volume>
<issue>6131</issue>
<fpage seq="a">430</fpage>
<lpage>430</lpage>
<permissions>
<copyright-statement>Copyright &#x00A9; 2013, American Association for the Advancement of Science</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder>American Association for the Advancement of Science</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:href="letters.pdf" />
<custom-meta-wrap>
<custom-meta><meta-name>Editor</meta-name><meta-value>Jennifer Sills</meta-value></custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>President Obama's announcement of the BRAIN Initiative has caused quite a stir. Many scientists welcome this large new thrust in neuroscience, whereas others question the technological feasibility of the project.</p>
<p>Whether or not the project becomes a major scientific success, it is an instructive example of how science policy decisions are made. A relatively small group of scientists and foundation people were able to create a compelling vision and then persuade senior policy-makers to embrace it.</p>
<p>In the broadest sense, it is good to see any new investment in basic science. However, is the BRAIN Initiative the very best use of the approximately $100M/year research investment? In terms of overall global good, would the money be better spent on malaria research? On better antibiotics for drug-resistant bacteria? On early detection of tumors?</p>
<p>The BRAIN Initiative highlights the fact that we do not have a systematic approach to assessing the nation's need for research and development.</p>
</body>
</article>